Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Artechouse's Newest Exhibition Uses Latest NASA Images
Artechouse, a digital art studio in New York City, has a new exhibition that lets visitors experience never-before-seen images that the James Webb space telescope captured. Cheddar News takes a peek inside the newest immersive experience.
Report: Shortage of Cancer Drugs
A report said that cancer centers are dealing with shortages of carboplatin and cisplatin, drugs that are used to treat cancers.
Health Expert Offers Tips for Coping with Poor Air Quality
With large swaths of the East Coast blanketed with smog, many are worried about their health. Mangala Narasimhan, director of critical care services at Northwell Health, offers some peace of mind with a handful of expert tips for coping with poor air quality. 
Hawaii's Kilauea Begins Erupting After 3-Month Pause
Kilauea, one of the most active volcanoes in the world, began erupting on Wednesday after a three-month pause, displaying spectacular fountains of mesmerizing, glowing lava that's a safe distance from people and structures in a national park on the Big Island.
Load More